Substituted 2-pyridine cyclohexane-1,4-diamine compounds

Details Substituted 2-pyridine cyclohexane-1,4-diamine compounds Substituted 2-pyridine cyclohexane-1,4-diamine compounds

2006-02-14

2006-02-14

Aulakh, Charanjit S. (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S277400, C546S085000, C546S329000, C514S292000, C514S357000

Reexamination Certificate

active

06998409

ABSTRACT:
Substituted 2-pyridine cyclohexane-1,4-diamine compounds, a method for their production, pharmaceutical compositions containing them, and the use of such substituted 2-pyridine cyclohexane-1,4-diamine compounds for treating pain and various other medical conditions.

REFERENCES:
patent: 4113866 (1978-09-01), Lednicer
patent: WO-99/36421 (1999-07-01), None
patent: WIPO- 01/87838 (2001-11-01), None
Bertorelli, R. et al. “Nociceptin/orphanin FQ and Its receptor: a potential target for drug discovery” Trends in Pharmacological Sciences, 21(7) (2000), pp. 233-234.
International Search Report.
Abdulla and Smith, J. Neurosci., 18, 1998, p. 9685-9694.
Ardati et al. Mol. Pharmacol., 51, 1997, p. 816-824.
Calo et al., Br. J. Pharmacol., 129, 2000, 1261-1283.
Champion and Kadowitz, Biochem. Biophys. Res. Comm., 234, 1997, p. 309-312.
Conner et al., Br. J. Pharmacol. 118, 1996, p. 205-207.
Darland et al., Trends in Neurosciences, 21, 1998, p. 215-221.
Faber et al., Br. J. Pharmacol., 119, 1996, p. 189-190.
Gumusel et al., Life Sci., 60, 1997, p. 141-145.
Gutiérrez et al., Abstract 536.18, Society for Neuroscience, vol. 24, 28thAnn. Meeting, Los Angeles, Nov. 7-12, 1998.
Hara et al., Br. J. Pharmacol. 121, 1997, p. 401-408.
Jenck et al., Proc. Natl. Acad. Sci. USA 94, 1997, 14854-14858.
Kapusta et al., Life Sciences, 60, 1997, PL 15-21.
King et al., Neurosci. Lett., 223, 1997, 113-116.
Knoflach et al., J. Neuroscience 16, 1996, p. 6657-6664.
Manabe et al., Nature, 394, 1997, p. 577-581.
Matthes et al., Mol. Pharmacol. 50, 1996, p. 447-450.
Meunier et al., Nature 377, 1995, p. 532-535.
Mogil et al., Neurosci. Letters 214, 1996, p. 131-134.
Mogil et al., Neuroscience 75, 1996, p. 333-337.
Mollereau et al., FEBS Letters, 341, 1994, p. 33-38.
Nishi et al., EMBO J., 16, 1997, p. 1858-1864.
Pomonis et al., NeuroReport, 8, 1996, p. 369-371.
Reinscheid et al., Science 270, 1995, p. 792-794.
Sandin et al., Eur. J. Neurosci., 9, 1997, p. 194-197.
Shu et al., Neuropeptides, 32, 1998, 567-571.
Vaughan et al., Br. J. Pharmacol. 117, 1996, p. 1609-1611.
Xu et al., NeuroReport, 7, 1996, 2092-2094.
Yamamoto and Nozaki-Taguchi, Anesthesiology, 87, 1997.
Yamamoto et al., Neuroscience, 81, 1997, p. 249-254.

Affiliated with

Also associated with

Rating

Substituted 2-pyridine cyclohexane-1,4-diamine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted 2-pyridine cyclohexane-1,4-diamine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2-pyridine cyclohexane-1,4-diamine compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3677300